TY - JOUR
T1 - The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis
AU - Kamizato, Kenyu
AU - Sato, Sho
AU - Shil, Subrata Kumar
AU - Umaru, Banlanjo A.
AU - Kagawa, Yoshiteru
AU - Yamamoto, Yui
AU - Ogata, Masaki
AU - Yasumoto, Yuki
AU - Okuyama, Yuko
AU - Ishii, Naoto
AU - Owada, Yuji
AU - Miyazaki, Hirofumi
PY - 2019/6/15
Y1 - 2019/6/15
N2 - Fatty acid binding protein 7 (FABP7)is expressed in astrocytes of the developing and mature central nervous system, and modulates astrocyte function by controlling intracellular fatty acid homeostasis. Astrocytes in the spinal cord have an important role in the process of myelin degeneration and regeneration. In the present study, the authors examined the role of FABP7 in astrocytes in a mouse model of experimental autoimmune encephalomyelitis (EAE), which is an established model of multiple sclerosis (MS). FABP7 was expressed in the white matter astrocytes and increased after EAE onset; particularly strong expression was observed in demyelinating regions. In FABP7-knockout (KO)mice, the onset of EAE symptoms occurred earlier than in wild type (WT)mice, and mRNA expression levels of inflammatory cytokines (IL-17 and TNF-α)were higher in FABP7-KO lumbar spinal cord than in WT lumbar spinal cord at early stage of EAE. Interestingly, however, the clinical score was significantly reduced in FABP7-KO mice compared with WT mice in the late phase of EAE. Moreover, the area exhibiting expression of fibronectin, which is an extracellular matrix protein mainly produced by astrocytes and inhibits remyelination of oligodendrocytes, was significantly decreased in FABP7-KO compared with WT mice. Collectively, FABP7 in astrocyte may have a role to protect from the induction of inflammation leading to demyelination in CNS at early phase of EAE. Moreover, FABP7 may be involved in the regulation of fibronectin production through the modification of astrocyte activation at late phase of EAE.
AB - Fatty acid binding protein 7 (FABP7)is expressed in astrocytes of the developing and mature central nervous system, and modulates astrocyte function by controlling intracellular fatty acid homeostasis. Astrocytes in the spinal cord have an important role in the process of myelin degeneration and regeneration. In the present study, the authors examined the role of FABP7 in astrocytes in a mouse model of experimental autoimmune encephalomyelitis (EAE), which is an established model of multiple sclerosis (MS). FABP7 was expressed in the white matter astrocytes and increased after EAE onset; particularly strong expression was observed in demyelinating regions. In FABP7-knockout (KO)mice, the onset of EAE symptoms occurred earlier than in wild type (WT)mice, and mRNA expression levels of inflammatory cytokines (IL-17 and TNF-α)were higher in FABP7-KO lumbar spinal cord than in WT lumbar spinal cord at early stage of EAE. Interestingly, however, the clinical score was significantly reduced in FABP7-KO mice compared with WT mice in the late phase of EAE. Moreover, the area exhibiting expression of fibronectin, which is an extracellular matrix protein mainly produced by astrocytes and inhibits remyelination of oligodendrocytes, was significantly decreased in FABP7-KO compared with WT mice. Collectively, FABP7 in astrocyte may have a role to protect from the induction of inflammation leading to demyelination in CNS at early phase of EAE. Moreover, FABP7 may be involved in the regulation of fibronectin production through the modification of astrocyte activation at late phase of EAE.
KW - astrocyte
KW - experimental autoimmune encephalomyelitis (EAE)
KW - fatty acid binding protein 7 (FABP7)
KW - multiple sclerosis (MS)
KW - spinal cord
UR - http://www.scopus.com/inward/record.url?scp=85065538121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065538121&partnerID=8YFLogxK
U2 - 10.1016/j.neuroscience.2019.03.050
DO - 10.1016/j.neuroscience.2019.03.050
M3 - Article
C2 - 31051217
AN - SCOPUS:85065538121
VL - 409
SP - 120
EP - 129
JO - Neuroscience
JF - Neuroscience
SN - 0306-4522
ER -